Substance Abuse Treatment Denials — Parity Law Explained

Federal parity law requires equal coverage for substance use treatment. Here is how to use it in your appeal.

5
 min. read
July 11, 2026
Substance Abuse Treatment Denials — Parity Law Explained

Substance Use Disorder Treatment Is a Medical Benefit —Not a Luxury

Substance use disorder is a recognized medical condition. Treatment — including detoxification, residential rehabilitation, intensive outpatient programs, and medication-assisted treatment — is medically necessary care. Insurance companies are required by federal law to cover it on parity with comparable physical health benefits.

When your insurer denies substance use disorder treatment,they may be breaking the law.

The Parity Law and Substance Use Disorder

The Mental Health Parity and Addiction Equity Act explicitly covers substance use disorder treatment alongside mental health benefits. This means:

  • Prior authorization requirements cannot be more stringent for substance use disorder treatment than for comparable physical health services
  • Day limits for residential treatment cannot be more restrictive than for comparable physical rehabilitation
  • Step therapy requirements cannot be more demanding than for comparable physical conditions
  • Network adequacy standards must provide equivalent access

The Most Common Substance Use Disorder Denial Types

Residential treatment denied as not medically necessary

The insurer says outpatient treatment is sufficient. The ASAM criteria — the gold standard for substance use disorder level of care — may support residential treatment when outpatient has failed or is clinically contraindicated. Your appeal should cite ASAM criteria explicitly.

Detox coverage ended before medical stability

Insurers frequently cut detox coverage after a predetermined number of days regardless of the patient's clinical status. If withdrawal symptoms persist or medical complications exist, premature discharge violates medical necessity standards.

Medication-assisted treatment denied

Buprenorphine, methadone, and naltrexone are evidence-based treatments for opioid use disorder. Denying MAT while covering other chronic disease medications is a parity violation.

IOP or PHP denied after residential discharge

Insurers sometimes discharge patients from residential treatment and then deny the recommended step-down care — intensive outpatient or partial hospitalization. This continuity-of-care denial is one of the most dangerous and most contestable.

What a Strong Appeal Includes

ASAM level of care criteria

The American Society of Addiction Medicine criteria provide the clinical standard for substance use disorder level of care decisions. Your appeal should explicitly reference ASAM criteria and show how your situation meets the threshold for the recommended level of care.

Treating physician letter

A detailed letter from the treating physician or licensed addiction counselor documenting the clinical necessity of the level of care, the history of prior treatment attempts, and the medical consequences of denial.

Parity analysis

Compare the denied benefit to acomparable physical health benefit — residential cardiac rehabilitation, inpatient physical rehabilitation — and document the disparity in how the plan applies its criteria.

How ClaimCompass Helps

ClaimCompass identifies parity violations in substance use disorder denials and generates a formally written appeal citing ASAM criteria and your federal rights.

Upload your denial at myclaimcompass.ai for a free analysis.